Clinical trial · Observational
Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Retrospective Analysis
Use of Multiparametric Magnetic Resonance Imaging in the Management of Head and Neck Cancer
NCT03991533CI-TRIAL-00056726completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators aim to identify specific MRI parameters that could improve diagnostic accuracy of metastatic cervical lymph nodes in patients with a squamous cell carcinoma in the head and neck region.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Lymph Node | — | UNRESOLVED | — |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Multiparametric MRI | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| multiparametric MRI | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- affected
- description
- patients with a histologically confirmed head and neck tumour
- interventionNames
- Other: multiparametric MRI
- label
- control
- description
- histologically confirmed Whartin tumour or pleomorphic adenoma of the parotid gland, without malignant transformation
- interventionNames
- Other: multiparametric MRI
Primary outcomes (3)
- measure
- discriminatory value of MRI perfusion curve
- timeFrame
- preoperative
- description
- differentiation between a metastatic cervical lymph node and a non-tumoural lymph node, as based on the final pathology report as the 'gold standard'
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients that received a pretreatment multiparametric MRI according to a standardized protocol between December 2016 and December 2018 * histophatologically proven SCC in the head and neck region * one or multiple clearly distinguishable cervical lymph node(s), that can be unambiguously correlated with the pathology report Exclusion Criteria: * patients not fulfilling abovementioned criteria * patients with thyroid or skin cancer * considerable artefact on MRI * previous surgery, irradiation or chemotherapy in the HN region
References
Publications (0)
Data not yet available
No reference posted for this study.